More than 3,600 U.S. health care workers perished in the first year of the pandemic, according to “Lost on the Frontline,” a 12-month investigation by The Guardian and KHN to track such deaths.
HHS has amended its emergency COVID-19 orders to allow healthcare workers to provide telehealth services across state lines, including administering authorized COVID-19 diagnostic tests.
An ATS-led international task force has released a guidance document to help guide clinicians on restoring elective in-person pulmonary and sleep services as COVID-19 incidence decreases in their communities.
Researchers have developed a membrane that can be attached to a regular N95 mask and replaced when needed.
Read More
Healthcare providers are increasingly interested in the role of ECMO to support critically ill patients in the current pandemic.
Read More
The ATS has issued the first official clinical practice guideline for sarcoidosis, which includes recommendations for diagnosis and detection.
Read More
As coronavirus cases surge in the United States with estimates that 5% of COVID-19 patients will need intensive care, US hospitals may quickly consume their limited supply of critical care beds and equipment.
Read More
RT Magazine is gathering data on how the industry’s healthcare professionals are staying informed on COVID-19 and other medical news.
Read More
The American Association for Respiratory Care has published a scope of practice for advanced practice respiratory therapists (APRT).
Read More
Elevated testosterone levels are associated with a reduced risk of asthma in women, new research shows.
Read More
A recent article published in the Journal of Allergy and Clinical Immunology looks at how machine learning and artificial intelligence could change the way asthma patients receive care.
Read More
New research shows that pulmonary hypertension prompted by exercise can predict survival rates in certain patients.
Read More
A study by researchers at Baptist Medical Center–Jacksonville found that a targeted intervention implemented within its RT department successfully prevented respiratory device-related pressure injuries in acutely ill patients.
Read More
Swiss drugmaker Novartis on Monday said it is jettisoning what it had hoped would be a billion-dollar-selling asthma drug, fevipiprant, from its development program after the medicine failed another set of key trials.
Read More
findings come from a study published in the American Journal of Preventive Medicine. Researchers tracked new lung disease among people who smoke and vape.
Read More